Boyle A. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes. THU-285.
Blaasspoeling met BCG-vaccin traint afweer blaaskankerpatiënten
feb 2023 | Immuuntherapie, Uro-oncologie, Vaccinatie